Morgan Stanley’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$659K Buy
+38,451
New +$809K ﹤0.01% 5468

Other funds holding ATTO

Morgan Stanley's ATTO Position: Q3 2026 in Review

Morgan Stanley opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 38,451 shares worth $659K. The stake represents ﹤0.01% of the portfolio and ranks #5468 among its holdings.

65 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Morgan Stanley held 38,451 shares of Attovia Therapeutics worth $659K as of Q3 2026.
  • Attovia Therapeutics was a new Morgan Stanley position in Q3 2026.
  • Attovia Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #5468 holding.
  • 65 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.